Vitality Watch

← Weekly issues

Week of 2026-10-26

2026-W44 · 2026-10-26 – 2026-11-01 · 1 finding

observational
Glucagon-Like Peptide-1 Receptor Agonists in Obese Heart Failure With Preserved Ejection Fraction.
In a nationwide VA cohort of patients with obese HFpEF and type 2 diabetes, initiating a GLP-1 receptor agonist was associated with a lower risk of all-cause death or heart failure hospitalization than starting a DPP-4 inhibitor or sulfonylurea (aHR 0.78).

build build 880 · 2bcef25 · 2026-11-18